Close Menu

NEW YORK – The Centers for Medicare & Medicaid Services is soliciting public input on Epigenomics' request for a national coverage determination for its Epi proColon blood test for colorectal cancer screening.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.